A detailed history of Jpmorgan Chase & CO transactions in Indexiq ETF Tr Iq Healthy Hear stock. As of the latest transaction made, Jpmorgan Chase & CO holds 16 shares of HART stock, worth $509. This represents 0.0% of its overall portfolio holdings.

Number of Shares
16
Previous 17 5.88%
Holding current value
$509
Previous $0 NaN%
% of portfolio
0.0%
Previous 0.0%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 12, 2024

SELL
$28.56 - $31.24 $28 - $31
-1 Reduced 5.88%
16 $0
Q4 2023

Feb 12, 2024

SELL
$25.84 - $28.89 $69,251 - $77,425
-2,680 Reduced 99.37%
17 $0
Q3 2023

Nov 14, 2023

BUY
$26.92 - $28.86 $1,561 - $1,673
58 Added 2.2%
2,697 $73,000
Q2 2023

Aug 11, 2023

SELL
$27.38 - $28.75 $1,588 - $1,667
-58 Reduced 2.15%
2,639 $75,000
Q1 2023

May 11, 2023

SELL
$0.0 - $27.39 $0 - $2,684
-98 Reduced 3.51%
2,697 $73,000
Q4 2022

Feb 13, 2023

BUY
$24.06 - $27.63 $67,247 - $77,225
2,795 New
2,795 $75,000

Others Institutions Holding HART

About INDEXIQ ETF TR IQ HEALTHY HEAR


  • Ticker HART
  • Sector ETFs
  • Industry ETFs
More about HART
Track This Portfolio

Track Jpmorgan Chase & CO Portfolio

Follow Jpmorgan Chase & CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jpmorgan Chase & CO, based on Form 13F filings with the SEC.

News

Stay updated on Jpmorgan Chase & CO with notifications on news.